Owl biomedical
US-based company pioneering MEMS technology for cell therapy and cancer diagnostics.
Founded
2011US-based company pioneering MEMS technology for cell therapy and cancer diagnostics.
Owl Biomedical, founded in Santa Barbara, United States, is dedicated to advancing MEMS (Micro-Electro-Mechanical Systems) technology as a sterile, live-cell sorting platform. Their core mission is to revolutionize cell therapy and cancer diagnostics by providing innovative solutions that enhance precision and efficiency in medical treatments. The company focuses on developing products and services that cater to the needs of healthcare providers and researchers in the field of cellular therapies and oncology.
Notable figures affiliated with Owl Biomedical include experts in MEMS technology and biotechnology. The company has attracted significant interest from investors specializing in medical technology innovations. Key achievements include the successful development and implementation of their MEMS-based cell sorting platform, which has demonstrated significant improvements in the accuracy and sterility of cell sorting processes. Owl Biomedical's impact is marked by its contributions to advancing cell therapy techniques and improving diagnostic capabilities in cancer treatment.
Companies similar to Owl biomedical include NanoCellect Biomedical, Owl Peak Technologies, Omniox and International Biomedical Devices.
Owl biomedical was founded in 2011.
Owl biomedical's headquarters is located in Goleta, CA, US.
Owl biomedical's most recent funding round was for $3M (USD) in January 2012.
As of Jan 23, 2012, Owl biomedical has disclosed funding of $4.1M (USD). Undisclosed round amounts are excluded.
Owl biomedical has 18 employees as of Feb 5, 2024.
International Biomedical Devices
